Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model

Praemer, 1999, Musculoskeletal conditions in the United States, Rosemont: Am Acad Ortho Surg Glowacki, 1998, Angiogenesis in fracture repair, Clin Orthop, S82, 10.1097/00003086-199810001-00010 Carano, 2003, Angiogenesis and bone repair, Drug Discov Today, 8, 980, 10.1016/S1359-6446(03)02866-6 Gerber, 2000, Angiogenesis and bone growth, Trends Cardiovasc Med, 10, 223, 10.1016/S1050-1738(00)00074-8 Schmid, 1997, The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment, Clin Oral Implants Res, 8, 244, 10.1034/j.1600-0501.1997.080311.x Winet, 1996, The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy, Bone, 19, 39S, 10.1016/S8756-3282(96)00133-0 Winet, 1990, A control model for tibial cortex neovascularization in the bone chamber, J Bone Miner Res, 5, 19, 10.1002/jbmr.5650050106 Sojo, 2005, Immunohistochemical study of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2, -4 (BMP-2, -4) on lengthened rat femurs, J Craniomaxillofac Surg, 33, 238, 10.1016/j.jcms.2005.02.004 Street, 2002, Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover, Proc Natl Acad Sci U S A, 99, 9656, 10.1073/pnas.152324099 Gerber, 1999, VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation, Nat Med, 5, 623, 10.1038/9467 Deckers, 2000, Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation, Endocrinology, 141, 1667, 10.1210/endo.141.5.7458 Pufe, 2002, Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat, Cell Tissue Res, 309, 387, 10.1007/s00441-002-0605-0 Bostrom, 1998, Expression of bone morphogenetic proteins in fracture healing, Clin Orthop, S116, 10.1097/00003086-199810001-00013 Lutolf, 2003, Repair of bone defects using synthetic mimetics of collagenous extracellular matrices, Nat Biotechnol, 21, 513, 10.1038/nbt818 Chang, 2004, Cranial repair using BMP-2 gene engineered bone marrow stromal cells, J Surg Res, 119, 85, 10.1016/j.jss.2003.08.003 Duggirala, 1996, The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2, Pharm Dev Technol, 1, 165, 10.3109/10837459609029891 Puleo, 1998, In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2, J Biomed Mater Res, 41, 104, 10.1002/(SICI)1097-4636(199807)41:1<104::AID-JBM13>3.0.CO;2-N Murakami, 2003, Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier, Biomaterials, 24, 2153, 10.1016/S0142-9612(03)00041-3 Kakudo, 2006, Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2, Life Sci, 79, 1847, 10.1016/j.lfs.2006.06.033 Patel ZS, Ueda H, Yamamoto M, Tabata Y, Mikos AG. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res, in press, doi:10.1007/s11095-008-9685-1. Patel ZS, Yamamoto M, Ueda H, Tabata Y, Mikos AG. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater, in press, doi:10.1016/j.actbio.2008.04.002. Hedberg, 2005, In vivo degradation of porous poly(propylene fumarate)/poly(dl-lactic-co-glycolic acid) composite scaffolds, Biomaterials, 26, 4616, 10.1016/j.biomaterials.2004.11.039 Fisher, 2002, Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model, J Biomed Mater Res, 59, 547, 10.1002/jbm.1268 Guldberg, 2003, Analyzing bone, blood vessels, and biomaterials with microcomputed tomography, IEEE Eng Med Biol Mag, 22, 77, 10.1109/MEMB.2003.1256276 Lee, 2003, Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice, J Control Release, 87, 49, 10.1016/S0168-3659(02)00349-8 Yamamoto, 2003, Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein, Biomaterials, 24, 4375, 10.1016/S0142-9612(03)00337-5 Blum, 2003, In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model, Hum Gene Ther, 14, 1689, 10.1089/104303403322611719 Castano-Izquierdo, 2007, Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential, J Biomed Mater Res A, 82, 129, 10.1002/jbm.a.31082 Kasper, 2006, Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect, J Biomed Mater Res A, 78, 335, 10.1002/jbm.a.30698 Sikavitsas, 2003, Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model, J Biomed Mater Res A, 67, 944, 10.1002/jbm.a.10126 Bodde EW, Boerman OC, Russel FG, Mikos AG, Spauwen PH, Jansen JA. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res A in press, doi:10.1002/jbm.a.31830. Ruhe, 2005, Biocompatibility and degradation of poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites, J Biomed Mater Res A, 74, 533, 10.1002/jbm.a.30341 Ruhe, 2006, Porous poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects, Tissue Eng, 12, 789, 10.1089/ten.2006.12.789 Holland, 2003, In vitro release of transforming growth factor-beta1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels, J Control Release, 91, 299, 10.1016/S0168-3659(03)00258-X Shung, 2003, Crosslinking characteristics of and cell adhesion to an injectable poly(propylene fumarate-co-ethylene glycol) hydrogel using a water-soluble crosslinking system, Tissue Eng, 9, 243, 10.1089/107632703764664710 Porter, 2000, Mechanical properties of a biodegradable bone regeneration scaffold, J Biomech Eng, 122, 286, 10.1115/1.429659 Hedberg, 2005, Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo, J Biomed Mater Res A, 72, 343, 10.1002/jbm.a.30265 van der Lubbe, 1988, A simple method for preparing thin (10 microM) histological sections of undecalcified plastic embedded bone with implants, Stain Technol, 63, 171, 10.3109/10520298809107179 Cowan, 2007, MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects, Tissue Eng, 13, 501, 10.1089/ten.2006.0141 Duvall, 2004, Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury, Am J Physiol Heart Circ Physiol, 287, H302, 10.1152/ajpheart.00928.2003 Murphy, 2004, Bone regeneration via a mineral substrate and induced angiogenesis, J Dent Res, 83, 204, 10.1177/154405910408300304 Leach, 2006, Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration, Biomaterials, 27, 3249, 10.1016/j.biomaterials.2006.01.033 Richardson, 2001, Polymeric system for dual growth factor delivery, Nat Biotechnol, 19, 1029, 10.1038/nbt1101-1029 Rai, 2007, Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair, J Biomed Mater Res A, 81, 888, 10.1002/jbm.a.31142 Akita, 2004, Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor, Wound Repair Regen, 12, 252, 10.1111/j.1067-1927.2004.012118.x Mayr-Wohlfart, 2002, Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts, Bone, 30, 472, 10.1016/S8756-3282(01)00690-1 Midy, 1994, Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts, Biochem Biophys Res Commun, 199, 380, 10.1006/bbrc.1994.1240 Deckers, 2002, Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A, Endocrinology, 143, 1545, 10.1210/endo.143.4.8719 Raida, 2006, Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells, Int J Mol Med, 18, 735 Kaigler, 2006, VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects, J Bone Miner Res, 21, 735, 10.1359/jbmr.060120 Leach, 2003, Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds, Biotech Bioeng, 82, 578, 10.1002/bit.10605 Simmons, 2004, Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells, Bone, 35, 562, 10.1016/j.bone.2004.02.027 Oest, 2007, Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects, J Orthop Res, 25, 941, 10.1002/jor.20372